COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 419: Articles 4181-4190  | Next

A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study)
Ramsay, J. A., Jones, M., Vande More, A. M., Hunt, S. L., Williams, P. C., Messer, M., Wood, N., Macartney, K., Lee, F. J., Britton, W. J., Snelling, T. L., Caterson, I. D.
10.1101/2023.06.14.23291380 — Posted: 2023-06-20
Vagus nerve inflammation contributes to dysautonomia in COVID-19
Woo, M. S., Shafiq, M., Fitzek, A., Dottermusch, M., Altmeppen, H., Mohammadi, B., Mayer, C., Bal, L. C., Raich, L., Matschke, J., Krasemann, S., Pfefferle, S., Brehm, T. T. S., Luetgehetmann, M., Schaedler, J., Addo, M. M., Schulze Zur Wiesch, J., Ondruschka, B., Friese, M. A., Glatzel, M.
10.1101/2023.06.14.23291320 — Posted: 2023-06-20
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity
Brunet-Ratnasingham, E., Morin, S., Randolph, H., Labrecque, M., Belair, J., Lima-Barbosa, R., Pagliuzza, A., Marchitto, L., Hultstrom, M., Niessl, J., Cloutier, R., Sreng, A., Brassard, N., Benlarbi, M., Prevost, J., Ding, S., Anand, S. P., Sannier, G., Bareke, E., Zeberg, H., Lipcsey, M., Frithiof, R., Larsson, A., Zhou, S., Nakanishi, T., Morrisson, D., Vezina, D., Bourassa, C., Gendron-Lepage, G., Medjahed, H., Point, F., Richard, J., Larochelle, C., Prat, A., Arbour, N., Durand, M., Richards, J. B., Moon, K., Chomont, N., Finzi, A., Tetreault, M., Barreiro, L., Wolf, G., Kaufmann, D. E.
10.1101/2023.06.14.23290814 — Posted: 2023-06-20
Crykey: Comprehensive Identification of SARS-CoV-2 Cryptic Mutations in Wastewater
Liu, Y., Sapoval, N., Treangen, T., Stadler, L.
10.1101/2023.06.16.23291524 — Posted: 2023-06-20
Individual healthcare-seeking pathways for tuberculosis in Nigeria private sector during the COVID-19 pandemic
Oga-Omenka, C., Rosapep, L., Huria, L., Vasquez, N. A., Olusola-Faleye, B., Kafi, M. A. H., Sassi, A., Nwosu, C., John, B., Adamu, A., Chijioke-Akaniro, O., Anyaike, C., Pai, M.
10.1101/2023.06.13.23291334 — Posted: 2023-06-20
High burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children with and without SARS-CoV-2
Watkins, T. A., Cheemarla, N. R., Hansel, K., Green, A. B., Amat, J. A. R., Lozano, R., Dudgeon, S. N., Landry, M. L., Schulz, W. L., Foxman, E. F.
10.1101/2023.06.17.23291498 — Posted: 2023-06-20
Covid19Vaxplorer: a free, online, user-friendly COVID-19 Vaccine Allocation Comparison Tool
Trejo, I., Hung, P.-Y., Matrajt, L.
10.1101/2023.06.15.23291472 — Posted: 2023-06-20
Anti-SARS-CoV-2 IgG profile of protein subunit, adenovector and mRNA vaccines
Reinig, S., Kuo, C., Wu, C.-C., Huang, S.-y., Yu, J.-S., Shih, S.-R.
10.1101/2023.06.16.23291455 — Posted: 2023-06-20
Real-world Effectiveness of BNT162b2 in Children and Adolescents in Preventing Infection and Severe Diseases with SARS-CoV-2 During the Delta and Omicron Periods: Findings from Trial Emulation Using an EHR-based Cohort
Wu, Q., Tong, J., Zhang, B., Zhang, D., Xu, J., Shen, Y., Li, L., Bailey, C., Bian, J., Christakis, D., Fitzgerald, M. L., Hirabayashi, K., Jhaveri, R., Khaitan, A., Lyu, T., Rao, S., Razzaghi, H., Schwenk, H., Wang, F., Gage Witvliet, M., Tchetgen Tchetgen, E. J., Morris, J. S., Forrest, C. B., Chen, Y.
10.1101/2023.06.16.23291515 — Posted: 2023-06-20
Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study
Yang, B., Lin, Y., Xiong, W., Liu, C., Gao, H., Ho, F., Zhou, J., Zhang, R., Wong, J., Cheung, J., Lau, E., Tsang, T., Xiao, J., Wong, I., Martin-Sanchez, M., Leung, G., Cowling, B. J., Wu, P.
10.1101/2023.06.20.23291593 — Posted: 2023-06-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).